These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2530770)

  • 1. A double-blind, multicentre study of paroxetine and mianserin in depression.
    Mertens C; Pintens H
    Acta Psychiatr Scand Suppl; 1989; 350():140. PubMed ID: 2530770
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E; Pelicier Y; Archambault JC; Chabannes JP; Clerc G; Desvilles M; Guibert M; Pagot R; Poisat JL; Thobie Y
    Acta Psychiatr Scand Suppl; 1989; 350():132-4. PubMed ID: 2530766
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
    Kuhs H; Rudolf GA
    Acta Psychiatr Scand Suppl; 1989; 350():145-6. PubMed ID: 2530773
    [No Abstract]   [Full Text] [Related]  

  • 4. Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin.
    Mertens C; Pintens H
    Acta Psychiatr Scand; 1988 Jun; 77(6):683-8. PubMed ID: 2970203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients.
    Bascara L
    Acta Psychiatr Scand Suppl; 1989; 350():141-2. PubMed ID: 2530771
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic.
    Miller SM; Naylor GJ; Murtagh M; Winslow G
    Acta Psychiatr Scand Suppl; 1989; 350():143-4. PubMed ID: 2530772
    [No Abstract]   [Full Text] [Related]  

  • 7. The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.
    Gagiano CA; Müller PG; Fourie J; Le Roux JF
    Acta Psychiatr Scand Suppl; 1989; 350():130-1. PubMed ID: 2530765
    [No Abstract]   [Full Text] [Related]  

  • 8. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind out-patient trial of indalpine vs mianserin.
    Naylor GJ; Martin B
    Br J Psychiatry; 1985 Sep; 147():306-9. PubMed ID: 3904886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of paroxetine on the electroencephalogram, electrocardiogram, and blood pressure.
    Edwards JG; Goldie A; Papayanni-Papasthatis S; Punter J; Sedgwick EM
    Acta Psychiatr Scand Suppl; 1989; 350():124. PubMed ID: 2530762
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
    Schlake HP; Kuhs H; Rolf LH; Bosse T; Schuhknecht E; Rudolf GA; Brune GG
    Acta Psychiatr Scand Suppl; 1989; 350():149-51. PubMed ID: 2530775
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
    Byrne MM
    Acta Psychiatr Scand Suppl; 1989; 350():138-9. PubMed ID: 2530768
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
    Kuhs H; Schlake HP; Rolf LH; Rudolf GA
    Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients.
    Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
    Acta Psychiatr Scand Suppl; 1989; 350():117-23. PubMed ID: 2530761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine plasma levels: lack of correlation with efficacy or adverse events.
    Tasker TC; Kaye CM; Zussman BD; Link CG
    Acta Psychiatr Scand Suppl; 1989; 350():152-5. PubMed ID: 2530776
    [No Abstract]   [Full Text] [Related]  

  • 16. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
    Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
    Psychopharmacol Bull; 1989; 25(2):267-71. PubMed ID: 2532373
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
    Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
    Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to the development of paroxetine, a novel antidepressant.
    Lassen JB
    Acta Psychiatr Scand Suppl; 1989; 350():13. PubMed ID: 2530764
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
    Nielsen OA; Morsing I; Petersen JS; Larsen T; Møller SE; Manniche PM; Skausig OB
    Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.